Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Regulation01:25

Drug Regulation

3.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.3K
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

393
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
393
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

283
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
283
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence01:19

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

226
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
226
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

216
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
216
Clinical Trials01:16

Clinical Trials

11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nanocarriers for lung health: ameliorating inflammation and cell aging using flavonoid-based nano nutrients.

Immunopharmacology and immunotoxicology·2026
Same author

Investigating the therapeutic potential of polymeric roflumilast nanosuspension in modulating asthma hallmarks using an in vivo ovalbumin model.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Protein and peptide based nanotherapeutics for the management of Alzheimer's disease: Current insights and future directions.

Ageing research reviews·2025
Same author

Recent Patents and Formulation Strategies for Osmotic Controlled Drug Delivery Systems: A Comprehensive Analysis.

Recent advances in drug delivery and formulation·2025
Same author

Correction: Bromelain: a review of its mechanisms, pharmacological effects and potential applications.

Food & function·2025
Same author

Unravelling the role of nanomedicine in attenuating inflammation, oxidative stress and cellular ageing in chronic obstructive pulmonary disease.

Archives of toxicology·2025
Same journal

Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Fenofibrate Lipid Lowering Agent.

Skinmed·2025
Same journal

Racial Disparities in the Management of Atopic Dermatitis: An Analysis of the National Ambulatory Medical Care Survey, 2012-2018.

Skinmed·2025
Same journal

"Pseudo-Chik Sign" Following COVID-19: Pigmentation Hitherto Unreported.

Skinmed·2025
Same journal

Hyperpigmented Scaly Lesions in the Axillae.

Skinmed·2025
Same journal

Sweet Syndrome-Like Disorder Induced by the Oxford-AstraZeneca<sup>®</sup> SARS-CoV-2 Vaccine.

Skinmed·2025
Same journal

Lockdown Lessons from Dermatology Consultations during the COVID-19 Pandemic in a Tertiary Care Center.

Skinmed·2025
See all related articles

Related Experiment Video

Updated: Apr 3, 2026

Eye Irritation Test EIT for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial RhCE Tissue Model
10:13

Eye Irritation Test EIT for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial RhCE Tissue Model

Published on: August 23, 2015

40.4K

Cosmetic Regulations: A Comparative Study.

Jyoti Suhag, Harish Dureja

    Skinmed
    |September 19, 2015
    PubMed
    Summary
    This summary is machine-generated.

    Global cosmetic regulations vary significantly, impacting trade and product safety. Harmonized cosmetic regulations are crucial for international market growth, innovation, and consumer health, addressing issues like allergic reactions and skin cancer.

    More Related Videos

    Author Spotlight: Enhancing Skin Model Diversity with Cost-Effective 3D Cellular Models
    08:32

    Author Spotlight: Enhancing Skin Model Diversity with Cost-Effective 3D Cellular Models

    Published on: October 20, 2023

    3.9K
    Evaluating the Effects of Different Polishing Methods on Color Stability of Dental Restorations in Pediatric Dentistry
    03:37

    Evaluating the Effects of Different Polishing Methods on Color Stability of Dental Restorations in Pediatric Dentistry

    Published on: June 6, 2025

    598

    Related Experiment Videos

    Last Updated: Apr 3, 2026

    Eye Irritation Test EIT for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial RhCE Tissue Model
    10:13

    Eye Irritation Test EIT for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial RhCE Tissue Model

    Published on: August 23, 2015

    40.4K
    Author Spotlight: Enhancing Skin Model Diversity with Cost-Effective 3D Cellular Models
    08:32

    Author Spotlight: Enhancing Skin Model Diversity with Cost-Effective 3D Cellular Models

    Published on: October 20, 2023

    3.9K
    Evaluating the Effects of Different Polishing Methods on Color Stability of Dental Restorations in Pediatric Dentistry
    03:37

    Evaluating the Effects of Different Polishing Methods on Color Stability of Dental Restorations in Pediatric Dentistry

    Published on: June 6, 2025

    598

    Area of Science:

    • Cosmetic Science
    • Regulatory Affairs
    • Public Health

    Background:

    • Cosmetic industry growth is driven by regulatory frameworks, compliance, efficacy, safety, and marketing.
    • Regulatory approaches differ globally, with stringent frameworks in the US, EU, and Japan, contrasting with less strict regulations in India, Brazil, and China.

    Purpose of the Study:

    • To provide insight into key cosmetic regulations concerning premarket approval, ingredient control, and labeling.
    • To focus on the cosmetic regulatory environments in the United States, European Union, Japan, and India.
    • To highlight the potential adverse health effects of cosmetics, such as allergic reactions and skin cancer.

    Main Methods:

    • Comparative analysis of cosmetic regulatory frameworks across key global markets.
    • Review of regulations pertaining to premarket approval, ingredient safety, and product labeling.
    • Examination of the impact of regulatory alignment on international trade and market growth.

    Main Results:

    • Significant disparities exist in cosmetic product regulation worldwide, influencing market access and innovation.
    • Stringent regulations in developed markets aim to ensure product safety and efficacy, while emerging markets present different challenges.
    • Cosmetics can pose health risks, including allergic reactions and potential carcinogenicity, underscoring the need for robust oversight.

    Conclusions:

    • Harmonization of cosmetic regulations is essential for facilitating international trade, fostering innovation, and ensuring consumer safety.
    • Stricter and more unified global cosmetic regulations are vital for public health, mitigating risks associated with cosmetic use.
    • Effective regulation is paramount for the responsible growth and development of the international cosmetic industry.